William Greenlee, PhD
Dr. Greenlee is a Medicinal Chemist, Research Director, and Project Manager with over 30 years of pharmaceutical research and industry experience. He has provided leadership to research groups that have advanced 20 drug candidates into preclinical development and 11 into clinical studies. He has contributed to medicinal chemistry programs for marketed drugs including Vasotec™ and Prinivil™, and directed programs that led to the marketed antithrombotic drug vorapaxar Zontivity™.
Dr. Greenlee has previously held roles at Merck Research Laboratories, where he was the Senior Director of Medicinal Chemistry, and Schering-Plough Research Institute, where he was the Vice President of CNS and Cardiovascular Chemistry and High-Throughput Synthesis. Dr. Greenlee is a Network Partner at Synergy Partners R&D Solutions, as well as BioMotiv, LLC and the Harrington Discovery Institute. Since 2001, Dr. Greenlee has been the Principal at MedChem Discovery Consulting, a company providing consulting services in preclinical drug discovery, lead optimization, candidate nomination, and due diligence.
Dr. Greenlee received his PhD in Chemistry from Harvard University and was an NIH Postdoctoral Fellow in Chemistry at Columbia University.